MedPath

Evaluating of safety and efficacy of Stylux Voluma dermal filler

Phase 2
Recruiting
Conditions
asolabial folds.
Changes in skin texture
R23.4
Registration Number
IRCT20190210042676N32
Lead Sponsor
ovajen Daru
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

18 -65 years old men and women
Moderate to severe nasolabial folds based on Allergan criteria.
The opportunity to accompany the visit programs and study process
Signing the informed consent form and agree to a 6-month follow-up.

Exclusion Criteria

Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
Planning to undergo any of these procedures at any time during the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of nasolabial folds. Timepoint: Before intervention and 2 weeks later. Method of measurement: 5 scale Allergan photo numeric grading.
Secondary Outcome Measures
NameTimeMethod
Depth, area and volume of nasolabial fold. Timepoint: Before intervention, 2 weeks, 3 and 6 months after intervention. Method of measurement: Visioface camera.;Thickness and density of dermis. Timepoint: Before intervention, 2 weeks and 6 months after intervention. Method of measurement: Skin ultrasound.
© Copyright 2025. All Rights Reserved by MedPath